Webinar: 5 Keys to Successful CME Outcomes Assessment
Jeremy C. Lundberg, CEO of EthosCE Learning Management System and DLC Solutions moderates this expert panel with Derek Dietze and Dr. Christopher Viereck of ImproveCME.com. Derek and Christopher shared their insights and expertise on what they consider the “5 Keys to Successful CME Outcomes Assessment.” The feedback from the program has been excellent and we hope that you will share this program with your colleagues.
- Increasing awareness on the five key factors to successful CME outcomes measurement.
- Changing from tactical to strategic planning for outcomes measurement.
- Learning how to align learning objectives with key assessment questions.
- Identifying areas for improving outcomes assessments through real-life case studies.
- Leveraging outcomes results to increase commercial support and demonstrate CME value.
Practical steps, discussion, case studies, and live Q&A are presented. Our program is designed for intermediate and advanced continuing education professionals in healthcare.
In addition, you can view and download the slide presentation at SlideShare.net. Please contact us with any questions or comments you may have.
About our Panel:
Jeremy C. Lundberg, MSSW (Moderator)
Chief Executive Officer of EthosCE Learning Management System and DLC Solutions
Jeremy C. Lundberg, MSSW, is the Chief Executive Officer of DLC Solutions, LLC, an award-winning technology firm specializing in web, e-learning, and social media solutions for continuing education (CE) in the health professionals. For twenty years, he has been creating innovative web solutions for major medical associations, health systems, and Fortune 100 pharmaceutical companies – such as the American Academy of Family Physicians, American Psychiatric Association, United Healthcare, and the University of Pennsylvania School of Medicine. Jeremy is a recipient of the Alliance for Continuing Education in the Health Professions President’s Award for his leadership in emerging technologies and is a peer-reviewer for Medicine 2.0 and the Cleveland Clinic Journal of Medicine. Jeremy is an active member of the Alliance for Continuing Education in the Health Professions, MedBiquitous, the Drupal Association, and the E-Learning Guild. He has served on the board of directors for multiple medical associations and not-for-profit organizations and is an accomplished author, scientific and technology researcher, and lecturer.
Derek T. Dietze, MA, FACME, CCMEP
President of Improve CME, LLC
Mr. Dietze has 20+ years experience as a CME professional and leads Improve CME’s work with many organizations within the CME community, helping them integrate practical outcomes measurement into their CME program, analyzing, reporting and publishing outcomes measurement results, and leveraging results to improve their CME. He speaks often at CME conferences, has authored several articles on outcomes measurement, is a Fellow of the Alliance for CME, and a past surveyor for the ACCME. Mr. Dietze is a Certified CME Professional, an editorial board member of the peer-reviewed educational outcomes measurement journal CE Measure, an assistant editor for the Alliance for CME Almanac, and a reviewer for CMExchange.com. He is an advocate for the open, transparent sharing of educational needs assessment and outcomes measurement information. He has a BSc in Biology from the University of Alberta in Edmonton, Canada, an MA in Communications from Brigham Young University in Provo, Utah, and lives near Phoenix, Arizona with his wife and children.
Christopher Viereck, PhD, CCMEP
Chief Scientific Officer of Improve CME, LLC
Dr. Viereck is the Chief Scientific Officer of Improve CME, LLC. His unique perspective and expertise is based on leadership and operational positions in clinical research and education with the pharmaceutical industry. Christopher has 10-years education experience at Sanofi Aventis including VP, Medical Education. He has 7-years experience as a clinical research associate, clinical trial study manager and Global Head of Medical Writing at Merck, Sanofi Aventis and Bayer Schering, respectively. Chris holds a PhD (Magna cum Laude) in developmental neurobiology from the University of Basel, Switzerland (supported by a grant from the Novartis Research Foundation), has published several articles based on his research and is a regular reviewer for Contemporary Clinical Trials.